| 0 (0%) | 09-27 14:24 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.53 | 1-year : | 1.78 |
| Resists | First : | 1.3 | Second : | 1.53 |
| Pivot price | 1.06  |
|||
| Supports | First : | 0.99 | Second : | 0.8 |
| MAs | MA(5) : | 1.08  |
MA(20) : | 1.01 |
| MA(100) : | 0.84 |
MA(250) : | 1.02 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 49.2 |
D(3) : | 51.8 |
| RSI | RSI(14): 59.8 |
|||
| 52-week | High : | 1.62 | Low : | 0.66 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SCYX ] has closed below upper band by 46.5%. Bollinger Bands are 15.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.12 |
| Low: | 1.02 - 1.03 | 1.03 - 1.04 |
| Close: | 1.06 - 1.07 | 1.07 - 1.09 |
Fri, 19 Sep 2025
Retail Surge: Is SCYX undervalued by DCF analysis - July 2025 Fed Impact & Verified Chart Pattern Signals - خودرو بانک
Tue, 16 Sep 2025
Tech Rally: What is the target price for SCYX stock - Weekly Trend Recap & Daily Profit Maximizing Tips - خودرو بانک
Tue, 09 Sep 2025
Can SCYNEXIS (NASDAQ:SCYX) Afford To Invest In Growth? - simplywall.st
Mon, 25 Aug 2025
Biotech Innovator SCYNEXIS to Showcase Drug-Resistant Infection Solutions at H.C. Wainwright Conference - Stock Titan
Sat, 16 Aug 2025
Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $4 - 富途牛牛
Wed, 13 Aug 2025
SCYNEXIS Restarts Key Phase 3 Trial but Faces Payment Dispute with Partner GSK over $30M Milestone - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 42 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 26.5 (%) |
| Shares Short | 496 (K) |
| Shares Short P.Month | 519 (K) |
| EPS | -0.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.12 |
| Profit Margin | 0 % |
| Operating Margin | -701 % |
| Return on Assets (ttm) | -27.2 % |
| Return on Equity (ttm) | -37.3 % |
| Qtrly Rev. Growth | 85.3 % |
| Gross Profit (p.s.) | 0.07 |
| Sales Per Share | 0.07 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -24 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -2.69 |
| PEG Ratio | 0 |
| Price to Book value | 0.95 |
| Price to Sales | 13.82 |
| Price to Cash Flow | -1.87 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|